Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients
2018 ◽
Vol 47
(12)
◽
pp. 1673-1681
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):